The report “Radiotherapy Market by
Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) &
Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium),
Application (Prostate, Breast, Cervical), End User, and Region – Global
Forecasts to 2022″, The global radiotherapy market is projected
to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a
CAGR of 6.8%. Technological advancements in radiotherapy systems,
increasing incidence and prevalence of cancer, rising geriatric
population, and growing adoption of radiotherapy devices and procedures
are the major factors driving market growth.
Browse 116 market data tables and 36 figures spread through 222 pages and in-depth TOC on “Radiotherapy
Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR)
& Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed,
Samarium), Application (Prostate, Breast, Cervical), End User, and
Region – Global Forecasts to 2022”
http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Early buyers will receive 10% customization on reports.
http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Early buyers will receive 10% customization on reports.
By type, the external beam radiotherapy segment is held the largest market share in 2016
Based on type, the external beam radiotherapy segment
accounted for the largest share of the market. Rising adoption of
linear accelerators for the treatment of cancer and development of
advanced radiotherapy technologies are the key factors driving the
growth of the external beam radiotherapy market segment.
By product type, the external beam radiotherapy segment is expected to grow at the highest CAGR
On the basis of product type, the radiotherapy market
is segmented into external beam radiotherapy, internal beam
radiotherapy/brachytherapy, and systemic radiotherapy. In 2016, the
external beam radiotherapy segment accounted for the largest market
share and is expected to grow at the highest CAGR. The large share of
this segment can primarily be attributed to factors such as growing
prevalence of cancer, product enhancements, and increasing adoption of
external beam radiotherapy devices in emerging countries.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=567
North America dominated the market in 2016
Geographically, the radiotherapy market is segmented
into North America, Europe, Asia-Pacific, and the Rest of the World.
North America accounted for the largest share of the market in 2016,
followed by Europe. A number of factors such as technological
advancements in radiotherapy equipment, growing number of cancer cases,
and rising focus of key players on expanding their presence in North
America are driving the growth of the radiotherapy market in this
region.
In 2016, Varian Medical Systems, Inc. (U.S.) and
Elekta AB (Sweden) dominated the global radiotherapy market. Other
prominent players include Accuray Incorporated (U.S.), Ion Beam
Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc.
(U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden),
Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation
(Japan).
Download Sample Report Pages: http://www.marketsandmarkets.com/requestsample.asp?id=567
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research
on 30,000 high growth niche opportunities/threats which will impact 70%
to 80% of worldwide companies’ revenues. Currently servicing 5000
customers worldwide including 80% of global Fortune 1000 companies as
clients. Almost 75,000 top officers across eight industries worldwide
approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
“Growth Engagement Model – GEM”. The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify
most important customers, write “Attack, avoid and defend” strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies
this year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research
ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence
and market research platform, “RT” connects over 200,000 markets and
entire value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
Article Credit: Healthcare DC
Comments
Post a Comment